| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 1992 | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | Asacol ® (mesalamine) Delayed-Release Tablets | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | Nifedical XL ® (NIFEDIPINE) Tablet, Film Coated Extended Release USP | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | Nifedical XL ® (NIFEDIPINE) Tablet, Film Coated Extended Release USP | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DG ™ beauty Daily Facial Moisturizer Broad Spectrum SPF15 Sunscreen | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS, USP | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | These highlights do not include all the information needed to use verapamil hydrochloride extended-release capsules (PM) safely and effectively. See full prescribing information for verapamil hydrochloride extended-release capsules (PM). Verapamil Hydrochloride Extended-release Capsules (PM) (Controlled Onset) for Oral use Initial U.S. Approval: 1998 | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | 162ffea4-4d08-4293-a03c-1256f8bb3533 | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | e69fa3b1-f8eb-4289-bc79-f40f25cfa418 | 1 | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole) | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ca5fa172-fd4a-4498-a88a-3265c5468384 | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 1997 | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | Kids-EEZE ® Chest Relief | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | Asacol ® (mesalamine) Delayed-Release Tablets | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL (MESALAMINE) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3702 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | NIFEDICAL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | NIFEDICAL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | LIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.] | 26 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ALTOPREV (LOVASTATIN) TABLET, EXTENDED RELEASE [SHIONOGI INC.] | 23 | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 17 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | METOPROLOL SUCCINATE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 15 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ] | 14 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | VERAPAMIL HYDROCHLORIDE PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 14 | |
| methacrylic acid - methyl methacrylate copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | VIDEX EC (DIDANOSINE) CAPSULE, DELAYED RELEASE [BRISTOL-MYERS SQUIBB COMPANY] | 13 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [WARNER CHILCOTT (US), LLC] | 10 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [SANDOZ INC] | 10 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED] | 9 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | SULAR (NISOLDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [SHIONOGI INC.] | 9 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | CARTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 8 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL (MESALAMINE) TABLET, DELAYED RELEASE [WARNER CHILCOTT (US), LLC] | 6 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 6 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | NIFEDIPINE TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | TAMSULOSIN HYDROCHLORIDE CAPSULE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 6 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL HD (MESALAMINE) TABLET, DELAYED RELEASE [WARNER CHILCOTT (US), LLC] | 5 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 5 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLIPIZIDE TABLET, FILM COATED, EXTENDED RELEASE [PAR PHARMACEUTICAL, INC.] | 5 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 4 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 4 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL (MESALAMINE) TABLET, DELAYED RELEASE [CARDINAL HEALTH] | 3 | |
| methacrylic acid - methyl methacrylate copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL (MESALAMINE) TABLET, DELAYED RELEASE [CARDINAL HEALTH] | 3 | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [ACTAVIS ELIZABETH LLC] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | NIFEDICAL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [WALGREENS COMPANY] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | TAMSULOSIN HYDROCHLORIDE CAPSULE, GELATIN COATED [CARDINAL HEALTH] | 3 | |
| methacrylic acid - methyl methacrylate copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL (MESALAMINE) TABLET [REMEDYREPACK INC. ] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DELZICOL (MESALAMINE) CAPSULE, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE (DILTIAZEM HYDROCHLORIDE) CAPSULE [CARDINAL HEALTH] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [THE KROGER CO.] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [KAISER PERMANENTE] | 2 | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [MEIJER DISTRIBUTION INC] | 2 | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | RYTARY (LEVODOPA AND CARBIDOPA) CAPSULE, EXTENDED RELEASE RYTARY (LEVODOPA AND CARBIDOPA) CAPSULE [IMPAX LABORATORIES, INC.] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE) CAPSULE [REMEDYREPACK INC. ] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [KAISER FOUNDATION HOSPITALS] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL (MESALAMINE) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS] | 1 | |
| methacrylic acid - methyl methacrylate copolymer (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | ASACOL TABLET, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE ) CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLYBURIDE (MICRONIZED) AND METFORMIN HYDROCHLORIDE TABLET [ACTAVIS INC.] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | GLYBURIDE (MICRONIZED) AND METFORMIN HYDROCHLORIDE TABLET [ACTAVIS PHARMA MANUFACTURING PVT. LTD.] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | LIALDA (MESALAMINE) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | METOPROLOL SUCCINATE TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | METOPROLOL SUCCINATE TABLET, FILM COATED, EXTENDED RELEASE [PROFICIENT RX LP] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | NIFEDICALXL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [TARGET CORPORATION] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [THE KROGER CO.] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [WAL-MART STORES INC] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [FREDS] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [CHAIN DRUG CONSORTIUM, LLC ] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [GERICARE PHARMACEUTICALS] | 1 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | INACTIVE INGREDIENT | 5KY68S2577 | OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [HEB] | 1 | |